Skip to main content
. 2013 Nov 11;2013:519080. doi: 10.1155/2013/519080

Table 2.

Comparison of several neurological, respiratory, and hemodynamic variables and dose of the used drugs between the start and the end (at 8 hours) of the study period.

Number (%) Start 8 hours P-value
Neurological
 Propofol (mg/kg/hr) 35 (71%) 2.3 ± 0.9 2.3 ± 1.0 0.99
 Midazolam (mg/kg/hr) 31 (69%) 0.2 ± 0.1 0.2 ± 0.1 0.81
 Remifentanil (µg/kg/min) 39 (87%) 0.2 ± 0.1 0.2 ± 0.1 0.80
 Cisatracurium (mg/kg/hr) 9 (20%) 0.1 ± 0.1 0.1 ± 0.05 0.77
 SAS (1–7) 45 (100%) 1.9 ± 1.1 1.6 ± 1.1 0.28
 GCS (3–15) 45 (100%) 4.5 ± 3.1 4.8 ± 3.7 0.67
Respiratory system
 pO2/FIO2 45 (100%) 290 ± 171 274 ± 149 0.64
 Minute ventilation (L/min) 45 (100%) 11.3 ± 3.5 11.2 ± 4.0 0.92
 pH 45 (100%) 7.3 ± 0.1 7.3 ± 0.1 0.45
 EVLWI (mL/kg) 45 (100%) 10.2 ± 3.7 10.3 ± 3.4 0.89
Hemodynamics
 Norepinephrine (µg/kg/min) 35 (78%) 0.2 ± 0.2 0.2 ± 0.2 0.90
 Dobutamine (µg/kg/min) 27 (60%) 4.1 ± 1.8 4.5 ± 2.2 0.49
 MAP (mmHg) 45 (100%) 79.6 ± 16.9 82.9 ± 21.1 0.41
 Heart rate (BPM) 45 (100%) 90.3 ± 25.4 88.0 ± 23.7 0.66
 CVP (mmHg) 45 (100%) 10.5 ± 5.3 10.1 ± 3.7 0.65
 TDCO (L/min) 45 (100%) 6.2 ± 2.1 6.9 ± 2.2 0.14
 GEF (%) 45 (100%) 22.8 ± 8.2 24.2 ± 8.6 0.45
 GEDVI (mL/BSA) 45 (100%) 715 ± 192 737 ± 162 0.56
 SVRI (dyne·s·cm−5/m²) 45 (100%) 1868 ± 764 1877 ± 793 0.56
 SVV (%) 45 (100%) 15.0 ± 8.8 12.3 ± 7.3 0.12
 PPV (%) 45 (100%) 14.6 ± 9.7 12.1 ± 7.9 0.17
Other
 IAP (mmHg) 45 (100%) 7.9 ± 2.9 8.8 ± 3.4 0.15
 Body Temperature (°C) 45 (100%) 35.4 ± 1.7 35.5 ± 1.7 0.76

CVP: central venous pressure.

EVLWI: extravascular lung water index.

GCS: Glasgow coma scale.

GEDVI: global end-diastolic volume index.

GEF: global ejection fraction.

IAP: intra-abdominal pressure.

MAP: mean arterial pressure.

PPV: pulse pressure variation.

SAS: sedation and agitation scale.

SVRI: systemic vascular resistance index.

SVV: stroke volume variation.

TDCO: thermodilution cardiac output.